Ki-67 as a predictor of response to neoadjuvant chemotherapy in breast cancer patients.
about
A Randomized Phase II Neoadjuvant Study of Cisplatin, Paclitaxel With or Without Everolimus in Patients with Stage II/III Triple-Negative Breast Cancer (TNBC): Responses and Long-term Outcome Correlated with Increased Frequency of DNA Damage ResponsMeroxest improves the prognosis of immunocompetent C57BL/6 mice with allografts of E0771 mouse breast tumor cells.Heterogeneity of Diffusion-Weighted Imaging in Tumours and the Surrounding Stroma for Prediction of Ki-67 Proliferation Status in Breast CancerA Comparison of Visual Assessment and Automated Digital Image Analysis of Ki67 Labeling Index in Breast Cancer.Prognostically Distinctive Subgroup in Pathologic N3 Breast Cancer.Histomorphological Factors Predicting the Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.The predictive value of Ki-67 before neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis.A single-institution experience of salvage therapy for patients with early and locally advanced breast cancer who progress during neoadjuvant chemotherapy.Biomarkers Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.The predictors of response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer.Ki-67 Expression by Immunohistochemistry and Quantitative Real-Time Polymerase Chain Reaction as Predictor of Clinical Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.The use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer.DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers.Ki-67 labeling index is a predictive marker for a pathological complete response to neoadjuvant chemotherapy in breast cancer: A meta-analysis.Tumor Infiltrating Lymphocytes in Breast Cancer Patients with Progressive Disease during Neoadjuvant Chemotherapy.Proliferation rate and breast cancer subtype, but not ALDH1 expression, predict pathological response to neoadjuvant chemotherapy in locally advanced breast cancer.Assessment of the predictive role of pretreatment Ki-67 and Ki-67 changes in breast cancer patients receiving neoadjuvant chemotherapy according to the molecular classification: a retrospective study of 1010 patients.Prognostic Significance of Reduction in Ki67 Index After Neoadjuvant Chemotherapy in Patients With Breast Cancer in Kerman Between 2009 And 2014.[18F]FDG and [18F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer.Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among Physicians
P2860
Q30253017-0075597A-B2B3-4A36-992A-574EBAC58567Q31134354-90936FEA-4E3F-46B7-8AB3-8C07D699AF05Q33767081-DA290A90-FA17-420C-9AC0-E09D14395EC2Q35940233-C801A74E-0386-4DD2-A244-4523CE3CCD4BQ37056923-D3444E5E-C6A2-4DE0-AFAC-618DFC9F3F16Q37316603-0ED41D4E-734F-4BEC-B382-126F8F16E0DFQ38771946-F7BF17AA-0C5A-4175-8305-CCF9A9404B74Q39154012-05EC7406-3F3B-4B0E-BB22-2D9CCF4549AAQ39685538-879B9260-B1A2-457F-8CF0-6A7CED43E6CAQ40695645-709EAA74-5A7F-4442-87B1-455E71D0E715Q47160829-DD0FAF41-4EA0-48CB-B259-50EA49E0EB1FQ47205521-C2E860AD-8AC2-4D32-8F5B-43F9140448C3Q47270135-6A5C43D1-2E05-42A6-A7CE-2E6CDD091E99Q49486164-C8A0B653-4CF8-4984-9628-AA51E2A9A751Q49987138-C19F3D92-A48A-438F-BCA6-C38999D946B5Q51017227-A948ED8B-1C0E-4AD4-B386-7BC589AB8FC2Q52685576-23E7011C-2415-4F60-A6D4-CE254B35F5E5Q55130351-071125F9-8684-44E5-AAED-6C88380BF57EQ55286904-421CE485-A9BE-428E-855D-2D8D2C5E2DB9Q56968394-7551A3A3-D05A-4EEB-8BF1-2B439534DE53
P2860
Ki-67 as a predictor of response to neoadjuvant chemotherapy in breast cancer patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ki-67 as a predictor of response to neoadjuvant chemotherapy in breast cancer patients.
@en
Ki-67 as a predictor of response to neoadjuvant chemotherapy in breast cancer patients.
@nl
type
label
Ki-67 as a predictor of response to neoadjuvant chemotherapy in breast cancer patients.
@en
Ki-67 as a predictor of response to neoadjuvant chemotherapy in breast cancer patients.
@nl
prefLabel
Ki-67 as a predictor of response to neoadjuvant chemotherapy in breast cancer patients.
@en
Ki-67 as a predictor of response to neoadjuvant chemotherapy in breast cancer patients.
@nl
P2093
P2860
P356
P1476
Ki-67 as a predictor of response to neoadjuvant chemotherapy in breast cancer patients.
@en
P2093
Heung Kyu Park
Kwan Il Kim
Kyung Hee Lee
Tae Hoon Lee
Tae Ryung Kim
Yong Soon Chun
P2860
P356
10.4048/JBC.2014.17.1.40
P577
2014-03-28T00:00:00Z